DENTSPLY SIRONA (NASDAQ:XRAY) Earns Equal Weight Rating from Analysts at Wells Fargo & Company

Equities researchers at Wells Fargo & Company began coverage on shares of DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) in a note issued to investors on Friday, Marketbeat reports. The brokerage set an "equal weight" rating and a $20.00 price target on the medical instruments supplier's stock. Wells Fargo & Company's price target would indicate a potential upside of 6.16% from the stock's previous close.

A number of other research analysts have also commented on XRAY. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating for the company in a research report on Friday, November 8th. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, February 7th. UBS Group lowered their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research note on Tuesday, December 3rd. Needham & Company LLC reissued a "buy" rating and issued a $25.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, February 11th. Finally, Leerink Partnrs lowered shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a report on Thursday, November 7th. Ten analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of "Hold" and an average target price of $25.85.

DENTSPLY SIRONA Price Performance

Shares of XRAY traded up $0.52 during midday trading on Friday, hitting $18.84. 2,971,845 shares of the company traded hands, compared to its average volume of 2,365,440. The stock has a 50-day moving average of $18.99 and a 200-day moving average of $21.83. The firm has a market cap of $3.75 billion, a P/E ratio of -9.10, a PEG ratio of 1.83 and a beta of 0.96. DENTSPLY SIRONA has a one year low of $17.21 and a one year high of $34.91. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of large investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in shares of DENTSPLY SIRONA by 0.3% during the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after purchasing an additional 65,478 shares during the period. First Eagle Investment Management LLC boosted its position in DENTSPLY SIRONA by 2.5% during the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after buying an additional 348,532 shares during the period. Nuance Investments LLC grew its holdings in DENTSPLY SIRONA by 25.0% in the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after acquiring an additional 1,975,404 shares during the period. Finally, Fuller & Thaler Asset Management Inc. raised its stake in shares of DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock valued at $219,018,000 after acquiring an additional 314,343 shares during the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.